74
Growth Score
pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
495579
Rezq Bio develops dendritic cell therapies for Type 1 Diabetes and autoimmune conditions.
About the Company
Rezq Bio is a biotechnology company focused on developing therapies for Type 1 Diabetes (T1D) and other localized autoimmune conditions. The company's lead asset is a Phase 1B/2A ready dendritic cell therapy aimed at treating early onset T1D. Built on the research of Drs. Trucco, Giannoukakis, and Finegold, Rezq Bio aims to arrest or
reverse the progression of T1D and similar autoimmune diseases.
